007570 — Ilyang Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSucker Stock

Market Cap
KR₩185bn
Enterprise Value
KR₩288bn
Revenue
KR₩272bn

Annual balance sheet for Ilyang Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2021 December 31st	2022 December 31st	2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS/A	ARS/A	ARS/A	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	43,480	12,402	12,813	11,818	28,654
Net Total Accounts Receivable
Net Total Receivables	56,101	53,479	52,336	48,713	48,912
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	136,340	118,418	123,659	125,187	147,762
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	174,782	177,146	181,124	216,421	220,675
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	419,261	402,916	392,607	431,027	457,331
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	167,920	145,328	139,263	157,549	171,172
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	195,523	168,493	165,743	195,076	219,728
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	223,737	234,423	226,864	235,951	237,603
Total Liabilities & Shareholders' Equity	419,261	402,916	392,607	431,027	457,331
Total Common Shares Outstanding
Total Preferred Shares Outstanding